Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    Migraine-friendly colours for the home

    Press Releases | December 4, 2020 | 11 London

    You may not realise it, but colour impacts migraines. 11 London worked with Teva Pharmaceuticals UK, Dulux Paints and the National Migraine Centre to test this theory among 1,200 migraine...

    The Future of Wearable and Implantable Devices

    Videos and Podcasts | December 3, 2020 | Impetus Digital

    Nance Dicciani & Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices....

    Designing Ethical AI and Healthcare Technologies

    Videos and Podcasts | December 3, 2020 | Impetus Digital

    Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics,...

    Attacking COVID-19 from All Angles

    Videos and Podcasts | December 3, 2020 | Impetus Digital

    Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating...

    Not waving but drowning. Reflections on data curation in the age of information overload

    White Papers and Resources | December 3, 2020 | Porterhouse Medical Group

    As of October 2019 there were over 300,000 clinical studies registered worldwide, compared to just over 2,100 in the year 2000’It’s common to hear colleagues and friends bemoan the huge...

    The patient journey: A long and winding road

    Press Releases | December 3, 2020 | Porterhouse Medical Group

    Reflections of a research executive

    Webcast

    White Papers and Resources | November 30, 2020 | Inizio

    The power of a good story: Turn your insights into effective storytelling with data visualisation

    Importance of Patient Advocacy in Improving Healthcare

    Videos and Podcasts | November 26, 2020 | Impetus Digital

    Eva Villalba, Executive Director of the Quebec Cancer Coalition, explores the importance of patient advocacy in improving healthcare. Among many other things, we dive into how the industry can help support...

    Improving Patient Care by Removing Barriers to Drug Accessibility

    Videos and Podcasts | November 26, 2020 | Impetus Digital

    Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and...

    Reimagining the Patient Journey

    Videos and Podcasts | November 26, 2020 | Impetus Digital

    Kimberly Tableman, CEO at Medicine X, discusses a myriad of topics related to digital transformation and patient centricity, including how digital health technologies can be used to reimagine the patient...